AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 132 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $785,000 | -27.3% | 68,869 | +2.0% | 0.08% | -25.5% |
| Q2 2021 | $1,080,000 | -11.4% | 67,487 | -1.1% | 0.10% | -25.0% |
| Q1 2021 | $1,219,000 | +349.8% | 68,236 | +240.0% | 0.14% | +353.3% |
| Q4 2020 | $271,000 | -51.7% | 20,070 | -57.9% | 0.03% | -63.0% |
| Q3 2020 | $561,000 | -14.0% | 47,690 | +8.0% | 0.08% | +9.5% |
| Q2 2020 | $652,000 | +41.1% | 44,154 | +29.1% | 0.07% | +13.8% |
| Q1 2020 | $462,000 | – | 34,192 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |